Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Philip Morris (PM – Research Report) and Church & ...
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
Philip Morris International Inc. (PM) stock saw a decline, ending the day at $117.15 which represents a decrease of $-4.71 or -3.87% from the prior close of $121.86. The stock opened at $119.96 and ...